MALAT1-related signaling pathways in colorectal cancer

被引:0
作者
Wen-Wen Xu
Jin Jin
Xiao-yu Wu
Qing-Ling Ren
Maryam Farzaneh
机构
[1] The Affiliated Hospital of Nanjing University of Chinese Medicine,Department of Gynaecology
[2] The Affiliated Hospital of Nanjing University of Chinese Medicine,Department of Surgical Oncology
[3] Ahvaz Jundishapur University of Medical Sciences,Fertility, Infertility and Perinatology Research Center
来源
Cancer Cell International | / 22卷
关键词
Colorectal cancer; Long non-coding RNAs; MALAT1; Signaling pathways; miRNAs;
D O I
暂无
中图分类号
学科分类号
摘要
Colorectal cancer (CRC) is one of the most lethal and prevalent solid malignancies worldwide. There is a great need of accelerating the development and diagnosis of CRC. Long noncoding RNAs (lncRNA) as transcribed RNA molecules play an important role in every level of gene expression. Metastasis‐associated lung adenocarcinoma transcript‐1 (MALAT1) is a highly conserved nucleus-restricted lncRNA that regulates genes at the transcriptional and post-transcriptional levels. High expression of MALAT1 is closely related to numerous human cancers. It is generally believed that MALAT1 expression is associated with CRC cell proliferation, tumorigenicity, and metastasis. MALAT1 by targeting multiple signaling pathways and microRNAs (miRNAs) plays a pivotal role in CRC pathogenesis. Therefore, MALAT1 can be a potent gene for cancer prediction and diagnosis. In this review, we will demonstrate signaling pathways associated with MALAT1 in CRC.
引用
收藏
相关论文
共 612 条
  • [1] Rawla P(2019)Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors Prz Gastroenterol 14 89-103
  • [2] Sunkara T(2015)Colorectal cancer Nat Rev Dis Primers 1 15065-15065
  • [3] Barsouk A(2020)The impact of the gut microbiota on prognosis after surgery for colorectal cancer—a systematic review and meta-analysis APMIS 128 162-176
  • [4] Kuipers EJ(2020)Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients OncoImmunology 9 1832347-177
  • [5] Grady WM(2016)Radiotherapy for colorectal cancer: current standards and future perspectives Visc Med 32 172-25
  • [6] Lieberman D(2021)Recent developments in antibody derivatives against colorectal cancer: a review Life Sci 265 118791-80
  • [7] Seufferlein T(2021)Nanodiagnosis and nanotreatment of colorectal cancer: an overview J Nanopart Res 23 1-54
  • [8] Sung JJ(2021)Overcoming obstacles to targeting muscarinic receptor signaling in colorectal cancer Int J Mol Sci 22 716-e18
  • [9] Boelens PG(2021)Long non-coding RNAs in colorectal cancer: novel oncogenic mechanisms and promising clinical applications Cancer Lett 504 67-40
  • [10] van de Velde CJH(2021)The effects of autophagy-related genes and lncRNAs in therapy and prognosis of colorectal cancer Front Oncol 11 582040-962